Clinical Trial

A Study of SPY002-072 in Healthy Volunteers

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated November 27, 2024 (before its estimated April 3, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a Phase 1, randomized, double-blind, placebo-controlled, single-dose, first in human safety, tolerability, and pharmacokinetic study of SPY002-072 in healthy participants.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-30.
Status change: Not Yet Recruiting → Recruiting 2024-11-25
Trial Details
NCT Number NCT06622070
Lead Sponsor Spyre Therapeutics, Inc.
Collaborators: Altasciences Company Inc.
Conditions Healthy
Enrollment 56 participants
Start Date 2024-11-18
Primary Completion 2026-04-03 (estimated)
Study Completion 2026-08-08 (estimated)
Updated on ClinicalTrials.gov 2024-11-27